REGENXBIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
CEOKenneth T. Mills
CEOKenneth T. Mills
Employees344
Employees344
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2008
Founded2008
Employees344
Employees344
RGNX Key Statistics
Market cap793.19M
Market cap793.19M
Price-Earnings ratio-2.66
Price-Earnings ratio-2.66
Dividend yield—
Dividend yield—
Average volume456.08K
Average volume456.08K
High today$16.44
High today$16.44
Low today$15.72
Low today$15.72
Open price$16.20
Open price$16.20
Volume305.66K
Volume305.66K
52 Week high$28.80
52 Week high$28.80
52 Week low$11.83
52 Week low$11.83
RGNX News
Simply Wall St 1d
REGENXBIO Inc. Not Doing Enough For Some Investors As Its Shares Slump 26% - Simply Wall StThe REGENXBIO Inc. ( ) share price has softened a substantial 26% over the previous 30 days, handing back much of the gains the stock has made lately. Instead o...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%